Pancreatic response of spontaneously hypertensive rats to the exogenous administration of melatonin in the spring and autumn
AbstractThe aim of the study was to investigate and compare the effect of exogenous melatonin administration on the morphofunctional state of the exocrine and endocrine parts of the pancreases of spontaneously-hypertensive rats (SHR line) in spring and autumn. The research was conducted on 48 male SHR line rats, age 4 months. The rats of the experimental group received melatonin (Unipharm Inc.,USA) every day (at 10 am) orally at a dose of 5 mg/kg of body weight. The duration of the experiment was 28 days. Morphofunctional activity of the exocrine and endocrine parts of the pancreas was assessed using morphological and morphometric methods. The histological preparations were made by the standard methods. The slides were photographed using a digital camera on a Nikon microscope. The morphometric analysis was performed on digital images using the computer program Image J. The morphological signs of the exocrine pancreas activity were greater in the control rats in spring compared to autumn. Conversely, the activity of the endocrine part of the pancreas in control animals was higher in autumn, than in spring. Exocrine pancreas activity increases after administration of melatonin regardless of time of the year. This was evidenced by the increase in size and height of the epithelial acini, and the number of exocrinocytes placed in them. The width of the interlobular and interacinus connective tissue layers in the pancreas decreased in spring (mostly) and in autumn. The activity of the endocrine part of the pancreas increased after administration of melatonin in spring. Proof of this was an increase in the number and size of islets of Langerhans and the number of endocrinocytes they contained, compared with control values. The number and size of islets of Langerhans, the number and density of the endocrinocytes they contained decreased in the rats which received melatonin in autumn. This indicates a reduction of the endocrine pancreas activity. These results may have implications for therapeutic dosing of melatonin in patients with hypertension in different seasons of the year.
Anisimov, V.N., 2007. Melatonin – rol’ v organizme, primenenie v klinike [Melatonin: Role in an organism, application in a clinic]. Sistema, Sankt-Peterburg (in Russian).
Barren, A.J., Rawlings, N.D., Woessner, J.F., 2012. Handbook of proteolytic enzymes. 3rd edition. Academic Press, London.
Borjigin, J., Zhang, L.S., Calinescu, A.A., 2012. Circadian regulation of pineal gland rhythmicity. Mol. Cell Endocrinol. 349(1), 13–19.
Cuesta, S., Kireev, R., García, C., Rancan, L., Vara, E., Tresguerres, J., 2013. Melatonin can improve insulin resistance and aging-induced pancreas alterations in senescence-accelerated prone male mice (SAMP8). Age (Dordr). 35(3), 659–671.
Dendorfer, A., Wolfrum, S., Dominiak, P., 1999. Pharmacology and cardiovascular implications of the kinin-kallikrein system. Jpn. J. Pharmacol. 79, 403–426.
Duchene, J., 2011. Kallikrein-kinin kystem in inflammatory diseases. Kinins, De Gruyter. P. 261–272.
El-Desouk, N., Basyony, M., El-Nenaey, M., Abdel-Magied, R., 2007. Histological and cytological studies on the effect of melatonin on experimentally induced pancreatic diabetes in rats. Egypt. J. Exp. Biol. (Zool.) 3, 69–82.
Hardeland, R., 2012. Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. Scientific World Journal 640389.
Kanter, M., Uysal, H., Karaca, T., Sagmanligil, H., 2006. Depression of glucose levels and partial restoration of pancreatic beta-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch. Toxicol. 80(6), 362–369.
Konenkov, V.I., Klimontov, V.V., Michurina, S.V., Prudnikova, M.A., Ishhenko, I.J., 2013. Melatonin pri saharnom diabete: Ot patofiziologii k perspektivam lechenija [Melatonin for patients with diabetes: From pathophysiology to treatment prospects]. Saharnyj Diabet 2, 11–16 (in Russian).
Korzhevsky, D., Gilarov, A., 2010. Оsnovy gistologicheskoj tehniki [Principles of histological techniques]. SpetsLit, Sankt-Peterburg (in Russian).
Kushnir, Y., Davydenko, I., 2009. Vplyv melatoninu na stan ostrivciv Langergansa pidshlunkovoi’ zalozy v aloksandiabetychnyh shhuriv [Influence of melatonin on condition pancreatic islets in aloksа-diabetic rats]. Svit Medycyny ta Biologii 4, 31–35 (in Ukrainian).
Lima, L., Reis, L., Lima, M., 2001. Influence of the pineal gland on the physiology, morphometry and morphology of pancreatic islets in rats. Rev. Brasil. Biol. 61(2), 333–340.
Lyssenko, V., Nagorny, C.L., Erdos, M.R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., Isomaa, B., Tuomi, T., Nilsson, P., Kuusisto, J., Tuomilehto, J., Boehnke, M., Altshuler, D., Sundler, F., Eriksson, J.G., Jackson, A.U., Laakso, M., Marchetti, P., Watanabe, R.M., Mulder, H., Groop, L., 2009. Common variant in MTNR1B associated with increased risk of type II diabetes and impaired early insulin secretion. Nat. Genet. 41(1), 82–88.
Mehmet, K., Hamdi, U., Turan, K., Ozdemir, S., 2006. Depression of glucose levels and partial restoration of pancreatic b-cell damage by melatonin in streptozotocin-induced diabetic rats. Arch. Toxicol. 80(6), 362–369.
Możdżan, M., Możdżan, M., Chałubiński, M., Wojdan, K., Broncel, M., 2014. The effect of melatonin on circadian blood pressure in patients with type II diabetes and essential hypertension. Arch. Med. Sci. 10(4), 669–675.
Mühlbauer, E., Albrecht, E., Hofmann, K., Bazwinsky-Wutschke, I., Peschke, E., 2011. Melatonin inhibits insulin secretion in rat insulinoma β-cells (INS-1) heterologously expressing the human melatonin receptor isoform MT2. J. Pineal Res. 51(3), 361–372.
Nagorny, C., Sathanoori, R., Voss, U., Mulder, H., Wierup, N., 2011. Distribution of melatonin receptors in murine pancreatic islets. J. Pineal Res. 50(4), 412–417.
Peschke, E., Bach, A., Villbaurer, E., 2006. Parallel signaling pathways of melatonin in the pancreatic beta-cell. J. Pineal Res. 40(2), 184–191.
Ramraeheya, R., Muller, D., Squires, P., 2008. Function and expression of melatonin receptors on human pancreatic islets. J. Pineal Res. 44(3), 273–279.
Shatilo, V.B., Bondarenko, E.V., Antonjuk-Shheglova, I.A., 2012. Metabolicheskie narushenija u pozhilyh bol’nyh s gipertonicheskoj bolezn’ju i ih korrekcija melatoninom [Metabolic disorders in elderly patients with hypertension and correction of melatonin]. Uspehi Gerontologii 25(1), 84–89 (in Russian).
Verigo, L., 2005. Izmenchivost’ soedinitel’no-tkannogo ostova podzheludochnoj zhelezy (Morfo-jeksperimental’noe issledovanie) [Variability of connective tissue of the pancreas (Morpho-experimental research)]. Fiziologija, Moscow (in Russian).
Yanko, R.V., Plotnіkova, L.M., 2016. Doslidzhennja morfologichnoi’ struktury pidshlunkovoi’ zalozy pislja vplyvu ekzogennogo melatoninu [The study of morphological structure of the pancreas after exposure to exogenous melatonin]. Biologichni doslidzhennja – 2016. Zhytomyr. P. 295–297 (in Ukrainian).
Yildirim, А., Tuncer, М., Pamukсu, О., Aktas, А., Akkus, М., 2009. Effects of іschemia / reperfusion on β сells of рancreas and рrotective еffects of мelatonin treatment. Int. J. Morphol. 27(2), 519–525.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.